https://www.linkedin.com/posts/parentprojectmd_pfizer-discontinues-development-of-investigational-activity-7224075311850688512-9KDd?
"PPMD is disappointed to learn that Pfizer Inc. has officially discontinued development of the company’s investigational mini-dystrophin #genetherapy, fordadistrogene movaparvovec. With this termination, Pfizer is not currently active in the Duchenne treatment space, which is a devastating setback for our community."
Luckily for Pfizer, there is a DMD drug developer looking to partner up at the moment...
GLTAH
Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-169
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.87M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 1.0¢ | $35.01K | 3.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4329046 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 3323423 | 6 |
View Market Depth
| Last trade - 15.35pm 23/06/2025 (20 minute delay) ? |
| PER (ASX) Chart |